Tryptamine Therapeutics completes phase 1b of IV-infused psilocin trial

By Proactive Investors / August 26, 2024 / www.youtube.com / Article Link


Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF) CEO Jason Carroll joins Proactive's Tylah Tully to discuss the completion of ...

Recent News

Gold stocks rise but lag broader equity gains
January 20, 2025 / www.canadianminingreport.com

Wesdome, Seabridge and Skeena report outstanding drill results
January 20, 2025 / www.canadianminingreport.com

Smaller juniors still financed even in more cautious market
January 13, 2025 / www.canadianminingreport.com

Gold stocks shrug off equity market decline on metal gain
January 13, 2025 / www.canadianminingreport.com

Geopolitical risk outlook unclear after US election
January 06, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok